Literature DB >> 1776244

Flow-cytometric analysis of erythrocytic blood group A antigen density profile.

Z N Berneman1, D R van Bockstaele, W M Uyttenbroeck, C Van Zaelen, J Cole-Dergent, L Muylle, M E Peetermans.   

Abstract

Blood group A antigen density on red blood cells (RBC) was studied using flow cytometry (FCM) and fluoresceinated polyclonal and monoclonal IgG anti-A antisera. Agglutination was a problem, which could only be solved by prefixation of the RBC with glutaraldehyde or formaldehyde. However, this treatment resulted in a significant reduction of the number of antigen sites as compared to the native (i.e. nonfixed) RBC. Two major new findings came out of this study: (1) A antigen density on native RBC seems to be higher than previously recognized, and (2) A antigen density distribution is probably non-Gaussian. The absolute number of A antigen sites was determined, using a human polyclonal IgG antiserum and commercially available absolute fluorescence standards. The site numbers on fixed RBC were comparable to those found by earlier radioimmunological studies (x 10(6)/RBC): A1, 1.07 +/- 0.28; A2, 0.21 +/- 0.09; A1B, 0.79 +/- 0.26 sites (mean +/- SD). The values found for native RBC were considerably higher (x 10(6)/RBC): A1, 2.86 +/- 0.95; A2, 0.47 +/- 0.29; A1B, 1.98 +/- 0.58 sites (mean +/- SD). With the 1 monoclonal and the 3 polyclonal antisera used in this study, and in contrast to Rh D, the erythrocytic A antigen density distribution of a given sample is highly asymmetrical. This non-Gaussian distribution profile does not seem to be affected by such factors as antibody heterogeneity, variability in antibody fluoresceination range, RBC density and reticulocyte content. This suggests that the asymmetrical A antigen distribution may be an intrinsic property of the RBC population.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1776244     DOI: 10.1111/j.1423-0410.1991.tb00958.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

1.  High molecular weight neoglycoconjugates for solid phase assays.

Authors:  Nadezhda V Shilova; Oxana E Galanina; Tatyana V Pochechueva; Alexander A Chinarev; Vasily A Kadykov; Alexander B Tuzikov; Nicolai V Bovin
Journal:  Glycoconj J       Date:  2005-02       Impact factor: 2.916

2.  Comparison of ABO antibody titers on the basis of the antibody detection method used.

Authors:  Seon Joo Kang; Young Ae Lim; Sae Yun Baik
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

3.  Cytoadherence in paediatric malaria: ABO blood group, CD36, and ICAM1 expression and severe Plasmodium falciparum infection.

Authors:  Christine M Cserti-Gazdewich; Aggrey Dhabangi; Charles Musoke; Isaac Ssewanyana; Henry Ddungu; Deborah Nakiboneka-Ssenabulya; Nicolette Nabukeera-Barungi; Arthur Mpimbaza; Walter H Dzik
Journal:  Br J Haematol       Date:  2012-08-22       Impact factor: 6.998

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.